224 related articles for article (PubMed ID: 30935840)
21. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
22. Cystic fibrosis related diabetes: Medical management.
Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
[TBL] [Abstract][Full Text] [Related]
23. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
Hameed S; Jaffé A; Verge CF
Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
[TBL] [Abstract][Full Text] [Related]
24. Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes.
Potter KJ; Boudreau V; Bonhoure A; Tremblay F; Lavoie A; Carricart M; Senior PA; Rabasa-Lhoret R
J Cyst Fibros; 2023 Jan; 22(1):50-58. PubMed ID: 36028423
[TBL] [Abstract][Full Text] [Related]
25. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
26. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
27. Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?
Dobson L; Sheldon CD; Hattersley AT
J R Soc Med; 2004; 97 Suppl 44(Suppl 44):26-35. PubMed ID: 15239291
[TBL] [Abstract][Full Text] [Related]
28. Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
[TBL] [Abstract][Full Text] [Related]
29. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
[TBL] [Abstract][Full Text] [Related]
30. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
Prentice B; Hameed S; Verge CF; Ooi CY; Jaffe A; Widger J
Expert Rev Respir Med; 2016 Jul; 10(7):799-811. PubMed ID: 27268400
[TBL] [Abstract][Full Text] [Related]
32. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
33. Epidemiology of cystic fibrosis-related diabetes.
Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
Fischman D; Nookala VK
Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
[TBL] [Abstract][Full Text] [Related]
35. Canadian Cystic Fibrosis-related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care.
Potter KJ; Coriati A; Hicks P; Lands LC; McKinney ML; Boudreau V; Bonhoure A; Luca P; Ho J; Tagougui S; Jober A; Pohl M; Rosolowsky ET; Gilmour J; Lam GY; Stephenson AL; Senior PA; Rabasa-Lhoret R; Kherani T
Can J Diabetes; 2023 Apr; 47(3):263-271.e1. PubMed ID: 36872137
[TBL] [Abstract][Full Text] [Related]
36. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
37. Abnormal glucose tolerance in a pediatric cystic fibrosis cohort: Trends in clinical outcomes and associated factors in the preceding years.
Nguyen CQT; Denis MH; Chagnon M; Rabasa-Lhoret R; Mailhot G
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):277-285. PubMed ID: 32981797
[TBL] [Abstract][Full Text] [Related]
38. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
Moran A; Pekow P; Grover P; Zorn M; Slovis B; Pilewski J; Tullis E; Liou TG; Allen H;
Diabetes Care; 2009 Oct; 32(10):1783-8. PubMed ID: 19592632
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
40. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
